Goldman Sachs
EXAS

Goldman Sachs’s Exact Sciences EXAS Stock Holding History

Goldman Sachs’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,410,459
Closed -$143M – 6643
2025
Q4 		$143M Buy
1,410,459
+1,004,321
+247% +$80.7M 0.02% 779
2025
Q3 		$22.2M Sell
406,138
-1,808,060
-82% -$90.3M ﹤0.01% 2153
2025
Q2 		$118M Buy
2,214,198
+1,486,137
+204% +$75.5M 0.02% 799
2025
Q1 		$31.5M Sell
728,061
-142,733
-16% -$7.23M 0.01% 1608
2024
Q4 		$48.9M Sell
870,794
-218,049
-20% -$13.6M 0.01% 1314
2024
Q3 		$74.2M Buy
1,088,843
+21,770
+2% +$1.23M 0.01% 953
2024
Q2 		$45.1M Buy
1,067,073
+116,536
+12% +$6.41M 0.01% 1234
2024
Q1 		$65.6M Buy
950,537
+34,772
+4% +$2.2M 0.01% 1003
2023
Q4 		$67.7M Sell
915,765
-9,534
-1% -$625K 0.01% 983
2023
Q3 		$63.1M Buy
925,299
+212,526
+30% +$18M 0.01% 974
2023
Q2 		$66.9M Buy
712,773
+377,676
+113% +$29.5M 0.01% 913
2023
Q1 		$22.7M Sell
335,097
-797,527
-70% -$51.3M 0.01% 1709
2022
Q4 		$56.1M Buy
1,132,624
+142,032
+14% +$5.8M 0.01% 1083
2022
Q3 		$32.2M Sell
990,592
-491,258
-33% -$20.3M 0.01% 1450
2022
Q2 		$58.4M Buy
1,481,850
+388,740
+36% +$20.8M 0.01% 1012
2022
Q1 		$76.4M Sell
1,093,110
-211,642
-16% -$15.5M 0.02% 946
2021
Q4 		$102M Buy
1,304,752
+743,774
+133% +$65.6M 0.02% 811
2021
Q3 		$53.5M Sell
560,978
-363,702
-39% -$38.4M 0.01% 1237
2021
Q2 		$115M Buy
924,680
+165,669
+22% +$19.8M 0.03% 651
2021
Q1 		$100M Buy
759,011
+18,512
+2% +$2.53M 0.03% 651
2020
Q4 		$98.1M Sell
740,499
-86,400
-10% -$10.4M 0.03% 630
2020
Q3 		$84.3M Buy
826,899
+160,269
+24% +$13.8M 0.02% 659
2020
Q2 		$58M Sell
666,630
-179,135
-21% -$14.3M 0.02% 849
2020
Q1 		$49.1M Buy
845,765
+131,441
+18% +$10.7M 0.02% 870
2019
Q4 		$66.1M Buy
714,324
+244,942
+52% +$21.5M 0.02% 962
2019
Q3 		$42.4M Sell
469,382
-220,419
-32% -$25.1M 0.01% 1207
2019
Q2 		$81.4M Buy
689,801
+6,619
+1% +$667K 0.02% 809
2019
Q1 		$59.2M Sell
683,182
-1,206,901
-64% -$103M 0.02% 987
2018
Q4 		$119M Buy
1,890,083
+1,259,805
+200% +$86.5M 0.04% 531
2018
Q3 		$49.7M Sell
630,278
-712,711
-53% -$46.5M 0.01% 1233
2018
Q2 		$80.3M Buy
1,342,989
+139,815
+12% +$7.52M 0.02% 895
2018
Q1 		$48.5M Buy
1,203,174
+182,446
+18% +$8.9M 0.01% 1216
2017
Q4 		$53.6M Buy
1,020,728
+60,972
+6% +$3.26M 0.01% 1243
2017
Q3 		$45.2M Sell
959,756
-162,375
-14% -$6.54M 0.01% 1362
2017
Q2 		$39.7M Buy
1,122,131
+155,418
+16% +$4.8M 0.01% 1403
2017
Q1 		$22.8M Buy
966,713
+358,182
+59% +$7.1M 0.01% 1791
2016
Q4 		$8.13M Sell
608,531
-290,183
-32% -$4.68M ﹤0.01% 2624
2016
Q3 		$16.7M Buy
898,714
+373,306
+71% +$6.58M 0.01% 2045
2016
Q2 		$6.44M Buy
525,408
+478,636
+1,023% +$3.61M ﹤0.01% 2661
2016
Q1 		$315K Sell
46,772
-168,666
-78% -$1.08M ﹤0.01% 5231
2015
Q4 		$1.99M Buy
215,438
+71,349
+50% +$663K ﹤0.01% 3635
2015
Q3 		$2.59M Buy
144,089
+45,896
+47% +$1.05M ﹤0.01% 3530
2015
Q2 		$2.92M Buy
98,193
+9,380
+11% +$236K ﹤0.01% 3465
2015
Q1 		$1.96M Sell
88,813
-445,852
-83% -$11.3M ﹤0.01% 3796
2014
Q4 		$14.7M Sell
534,665
-1,305,949
-71% -$31.8M ﹤0.01% 2050
2014
Q3 		$35.7M Sell
1,840,614
-856,423
-32% -$15.7M 0.01% 1334
2014
Q2 		$45.9M Sell
2,697,037
-589,299
-18% -$8.11M 0.01% 1171
2014
Q1 		$46.6M Buy
3,286,336
+5,338
+0.2% +$72.1K 0.02% 1113
2013
Q4 		$38.6M Buy
3,280,998
+982,094
+43% +$11.3M 0.01% 1243
2013
Q3 		$27.1M Buy
2,298,904
+527,640
+30% +$6.77M 0.01% 1373
2013
Q2 		$24.6M Buy
+1,771,264
New +$19.2M 0.01% 1377

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Goldman Sachs's EXAS Position: Q1 2026 in Review

Goldman Sachs sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,410,459 shares — an estimated $143M sold.

Goldman Sachs first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $143M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Goldman Sachs reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Goldman Sachs sold 1,410,459 Exact Sciences shares in Q1 2026, an estimated $143M.
  • Goldman Sachs first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • Goldman Sachs's Exact Sciences position peaked at $143M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.